Enregistrement :
2
de
13
(2018-05-25
à
2018-09-01)
Subvention, Contribution ou autre avantage financier
Source of funds sought is from Canada’s Strategic Innovation Fund (SIF). BioVectra will utilize these funds for API and scaled biologics capacity expansion in the Atlantic Region.